Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000801445 | SCV000941221 | likely benign | Noonan syndrome 9 | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002458466 | SCV002739600 | uncertain significance | Cardiovascular phenotype | 2021-07-27 | criteria provided, single submitter | clinical testing | The p.A86V variant (also known as c.257C>T), located in coding exon 3 of the SOS2 gene, results from a C to T substitution at nucleotide position 257. The alanine at codon 86 is replaced by valine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV000801445 | SCV002763147 | uncertain significance | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Fulgent Genetics, |
RCV000801445 | SCV002785817 | uncertain significance | Noonan syndrome 9 | 2021-09-07 | criteria provided, single submitter | clinical testing |